Jump to content

Tienoxolol

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by ThaesOfereode (talk | contribs) at 03:24, 30 June 2024 (Added {{One source}} tag). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Tienoxolol
Names
IUPAC name
Ethyl 2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-(thiophene-2-carbonylamino)benzoate
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C21H28N2O5S/c1-5-27-20(26)16-11-14(23-19(25)18-7-6-10-29-18)8-9-17(16)28-13-15(24)12-22-21(2,3)4/h6-11,15,22,24H,5,12-13H2,1-4H3,(H,23,25)
    Key: PHMRLCQEIQGCHH-UHFFFAOYSA-N
  • InChI=1/C21H28N2O5S/c1-5-27-20(26)16-11-14(23-19(25)18-7-6-10-29-18)8-9-17(16)28-13-15(24)12-22-21(2,3)4/h6-11,15,22,24H,5,12-13H2,1-4H3,(H,23,25)
    Key: PHMRLCQEIQGCHH-UHFFFAOYAL
  • CCOC(=O)C1=C(C=CC(=C1)NC(=O)C2=CC=CS2)OCC(CNC(C)(C)C)O
Properties
C21H28N2O5S
Molar mass 420.52 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Tienoxolol is a beta adrenergic receptor antagonist.[1]

References

[edit]
  1. ^ Mahé, N; Do, B; Nicolaï, B; Rietveld, IB; Barrio, M; Tamarit, JL; Céolin, R; Guéchot, C; Teulon, JM (2012). "Crystal structure and solid-state studies of aged samples of tienoxolol, an API designed against hypertension". International Journal of Pharmaceutics. 422 (1–2): 47–51. doi:10.1016/j.ijpharm.2011.10.025. hdl:2117/14578. PMID 22027392.